The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidism

Pharmacological Reports

Volumn 68, Issue 2, 2016, Pages 490-494

  Krysiak, Robert ^a   Gilowska, Małgorzata ^a,b   Szkróbka, Witold ^a   Okopień, Bogusław ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Provincial Hospital   (Poland)

Author keywords

Amiodarone; Diabetes mellitus; Hypothalamic pituitary thyroid axis; Metformin

Indexed keywords

AMIODARONE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LIPID; METFORMIN; PROLACTIN; SOMATOMEDIN C; THYROID HORMONE; THYROTROPIN; TRIACYLGLYCEROL; PROTIRELIN; THYROXINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; ENDOCRINE FUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HOMEOSTATIC MODEL ASSESSMENT 1 OF INSULIN RESISTANCE RATIO; HUMAN; HYPOTHALAMIC PITUITARY THYROID AXIS; HYPOTHYROIDISM; INSULIN BLOOD LEVEL; LIPID ANALYSIS; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OVERT HYPOTHYROIDISM; PROLACTIN BLOOD LEVEL; SEX DIFFERENCE; SUBCLINICAL HYPOTHYROIDISM; THYROID DISEASE; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY; THYROID GLAND;

AGED; AMIODARONE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHYROIDISM; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MALE; METFORMIN; MIDDLE AGED; PROLACTIN; THYROID GLAND; THYROTROPIN; THYROTROPIN-RELEASING HORMONE; THYROXINE;

EID: 84956907803     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2015.11.010     Document Type: Article

References (32)

1. American Diabetes Association Standards of medical care in diabetes - 2015. Approaches to glycemic treatment Diabetes Care 38 Suppl. 1 2015 S42 S48
2. U.K. Prospective Diabetes Study Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group Lancet 352 1998 854 865
3. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403
4. J.H. Scarpello, and H.C. Howlett Metformin therapy and clinical uses Diabetes Vasc Dis Res 5 2008 157 167
5. R.A. Vigersky, A. Filmore-Nassar, and A.R. Glass Thyrotropin suppression by metformin J Clin Endocrinol Metab 91 2006 225 227
6. C. Cappelli, M. Rotondi, I. Pirola, B. Agosti, E. Gandossi, U. Valentini, and et al. TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients Diabetes Care 32 2009 1589 1590
7. M.L. Isidro, M.A. Penín, R. Nemiña, and F. Cordido Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy Endocrine 32 2007 79 82
8. S. Morteza Taghavi, H. Rokni, and S. Fatemi Metformin decreases thyrotropin in overweight women with polycystic ovarian syndrome and hypothyroidism Diabetes Vasc Dis Res 8 2011 47 48
9. R. Lupoli, A. Di Minno, A. Tortora, P. Ambrosino, G.A. Lupoli, and M.N. Di Minno Effects of treatment with metformin on TSH levels: a meta-analysis of literature studies J Clin Endocrinol Metab 99 2014 E143 E148
10. R. Krysiak, and B. Okopień The effect of metformin on the hypothalamic-pituitary-thyroid axis in women with polycystic ovary syndrome and subclinical hypothyroidism J Clin Pharmacol 55 2015 45 49
11. S.E. Oleandri, M. Maccario, R. Rossetto, M. Procopio, S. Grottoli, E. Avogadri, and et al. Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity J Endocrinol Invest 22 1999 134 140
12. R. Krysiak, W. Szkróbka, and B. Okopień The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and subclinical hyperthyroidism Exp Clin Endocrinol Diabetes 123 2015 205 208
13. T. Pappa, and M. Alevizaki Metformin and thyroid: an update Eur Thyroid J 2 2013 22 28
14. C. Cappelli, M. Rotondi, I. Pirola, B. Agosti, A.M. Formenti, P. De Cata, and et al. Metformin-induced thyrotropin suppression is not associated with cardiac effects Hormones (Athens) 13 2014 252 258
15. B.I. Joffe, and L.A. Distiller Diabetes mellitus and hypothyroidism: strange bedfellows or mutual companions? World J Diabetes 5 2014 901 904
16. K. Kumar, and P.J. Zimetbaum Antiarrhythmic drugs 2013: state of the art Curr Cardiol Rep 15 2013 410
17. O. Asghar, U. Alam, S.A. Hayat, R. Aghamohammadzadeh, A.M. Heagerty, and R.A. Malik Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions Curr Cardiol Rev 8 2012 253 264
18. E. Martino, L. Bartalena, F. Bogazzi, and L.E. Braverman The effects of amiodarone on the thyroid Endocr Rev 22 2001 240 254
19. S.A. Eskes, and W.M. Wiersinga Amiodarone and thyroid Best Pract Res Clin Endocrinol Metab 23 2009 735 751
20. S.K. Narayana, D.R. Woods, and C.J. Boos Management of amiodarone-related thyroid problems Ther Adv Endocrinol Metab 2 2011 115 126
21. American College of Cardiology Foundation, American Heart Association, European Society, L.S. Wann, A.B. Curtis, K.A. Ellenbogen, and et al. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines Circulation 127 2013 1916 1926
22. K. Labbuzek, D. Suchy, B. Gabryel, A. Bielecka, S. Liber, and B. Okopień Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide Pharmacol Rep 62 2010 956 965
23. R. Krysiak, and B. Okopień Thyrotropin-lowering effect of metformin in a patient with resistance to thyroid hormone Clin Endocrinol 75 2011 404 406
24. G. Chen, S. Xu, K. Renko, and M. Derwahl Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents J Clin Endocrinol Metab 97 2012 E510 E520
25. T. Ittermann, M.R. Markus, S. Schipf, M. Derwahl, C. Meisinger, and H. Völzke Metformin inhibits goitrogenous effects of type 2 diabetes Eur J Endocrinol 169 2013 9 15
26. J. Rezzónico, M. Rezzónico, E. Pusiol, F. Pitoia, and H. Niepomniszcze Metformin treatment for small benign thyroid nodules in patients with insulin resistance Metab Syndr Relat Disord 9 2011 69 75
27. C. Chau-Van, M. Gamba, R. Salvi, R.C. Gaillard, and F.P. Pralong Metformin inhibits adenosine 5'-monophosphate-activated kinase activation and prevents increases in neuropeptide Y expression in cultured hypothalamic neurons Endocrinology 148 2007 507 511
28. L.H. Duntas, J. Orgiazzi, and G. Brabant The interface between thyroid and diabetes mellitus Clin Endocrinol 75 2011 1 9
29. M. López, L. Varela, M.J. Vázquez, S. Rodríguez-Cuenca, C.R. González, V.R. Velagapudi, and et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance Nat Med 16 2010 1001 1008
30. M.H. Zou, and Y. Wu AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function Clin Exp Pharmacol Physiol 35 2008 535 545
31. Y.Y. Cheng, H.B. Leu, T.J. Chen, C.L. Chen, C.H. Kuo, S.D. Lee, and C.L. Kao Metformin-inclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study J Stroke Cerebrovasc Dis 23 2014 e99 e105
32. Z. Szybiński, and Polish Council for Control of Iodine Deficiency Disorders Work of the Polish Council for Control of Iodine Deficiency Disorders, and the model of iodine prophylaxis in Poland Endokrynol Pol 63 2012 156 160